Loading…

PACS-2 mediates the ATM and NF-κB-dependent induction of anti-apoptotic Bcl-xL in response to DNA damage

Nuclear factor kappa B (NF- κ B) promotes cell survival in response to genotoxic stress by inducing the expression of anti-apoptotic proteins including Bcl-xL, which protects mitochondria from stress-induced mitochondrial outer membrane permeabilization (MOMP). Here we show that the multifunctional...

Full description

Saved in:
Bibliographic Details
Published in:Cell death and differentiation 2016-09, Vol.23 (9), p.1448-1457
Main Authors: Barroso-González, J, Auclair, S, Luan, S, Thomas, L, Atkins, K M, Aslan, J E, Thomas, L L, Zhao, J, Zhao, Y, Thomas, G
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Nuclear factor kappa B (NF- κ B) promotes cell survival in response to genotoxic stress by inducing the expression of anti-apoptotic proteins including Bcl-xL, which protects mitochondria from stress-induced mitochondrial outer membrane permeabilization (MOMP). Here we show that the multifunctional sorting protein Pacs-2 (phosphofurin acidic cluster sorting protein-2) is required for Bcl-xL induction following DNA damage in primary mouse thymocytes. Consequently, in response to DNA damage, Pacs-2 −/− thymocytes exhibit a blunted induction of Bcl-xL, increased MOMP and accelerated apoptosis. Biochemical studies show that cytoplasmic PACS-2 promotes this DNA damage-induced anti-apoptotic pathway by interacting with ataxia telangiectasia mutated (ATM) to drive NF- κ B activation and induction of Bcl-xL. However, Pacs-2 was not required for tumor necrosis factor- α -induced NF- κ B activation, suggesting a role for PACS-2 selectively in NF- κ B activation in response to DNA damage. These findings identify PACS-2 as an in vivo mediator of the ATM and NF- κ B-dependent induction of Bcl-xL that promotes cell survival in response to DNA damage.
ISSN:1350-9047
1476-5403
DOI:10.1038/cdd.2016.23